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Objectives. The aim of this study was to determine the preva-
lence of aortic sclerosis and stenosis in the elderly and to identify
clinical factors associated with degenerative aortic valve disease.
Background. Several lines of evidence suggest that degenerative
aortic valve disease is not an inevitable consequence of aging and
may be associated with specific clinical factors.
Methods. In 5,201 subjects >265 years of age enrolled in the
Cardiovascular Health Study, the relation between aortic sclerosis
or stenosis identified on echocardiography and clinical risk
factors for atherosclerosis was evaluated by using stepwise logistic
regression analysis.
Results. Aortic valve sclerosis was present in 26% and aortic
valve stenosis in 2% of the entire study cohort; in subjects >275
years of age, sclerosis was present in 37% and stenosis in 2.6%.
Independent clinical factors associated with degenerative aortic
valve disease included age (twofold increased risk for each 10-year
increase in age), male gender (twofold excess risk), present
smoking (35% increase in risk) and a history of hypertension (20%
increase in risk). Other significant factors included height and
high lipoprotein(a) and low density lipoprotein cholesterol levels.
Conclusions. Clinical factors associated with aortic sclerosis
and stenosis can be identified and are similar to risk factors for
atherosclerosis.
(J Am Coll Cardiol 1997;29:630–4)
q1997 by the American College of Cardiology
Degenerative aortic valve disease, characterized macroscopi-
cally as increased leaflet thickness, stiffening and calcification,
without commissural fusion, is common among the elderly,
with echocardiographic evidence of calcification in 14% and
moderate to severe valve obstruction in 5% of a randomly
selected group of men and women aged 75 to 86 years (2).
Milder degrees of aortic valve calcification are even more
common, often designated as valve sclerosis on echocardiog-
raphy.
Although the prevalence of aortic valve disease increases
with age, several lines of evidence suggest that degenerative
aortic valve disease is not simply a consequence of aging.
Aortic valve disease is not seen universally among the elderly,
as 25% to 45% of octogenarians have no evidence of aortic
valve calcification (2,3). In addition, the early lesion of calcific
aortic valve disease appears to involve an active process with
some similarities to atherosclerosis, including lipid deposition
(apo B, apo(a) and apo E), macrophage infiltration and
production of osteopontin and other proteins (4–8), implicat-
ing atherosclerosis risk factors in the development of aortic
valve disease. This possibility is supported by preliminary
studies that have identified risk factors for calcific aortic
stenosis including smoking, hypertension, hyperlipidemia, li-
poprotein(a) [LP(a)] levels and diabetes (9–13). Some of these
studies have been limited by a small sample size, possible
selection bias and retrospective study designs. Among .500
elderly subjects in the Helsinki Aging Study (14), age, hyper-
tension and body mass index were independent predictors of
aortic valve calcification (14).
The Cardiovascular Health Study (CHS) is a prospective
population-based study of the elderly that includes extensive
clinical and echocardiographic data. The purpose of this study
was to utilize the CHS data base to 1) determine the preva-
lence of aortic valve sclerosis and stenosis, and 2) identify
clinical factors associated with degenerative aortic valve dis-
ease.
Methods
The CHS is a prospective, longitudinal study of 5,201 men
(n5 2,239) and women (n5 2,962)$65 years of age randomly
selected from households identified onMedicare eligibility lists
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in four communities in the United States: Forsyth County,
North Carolina; Sacramento County, California; Washington
County, Maryland; and Allegheny County, Pennsylvania. Of
9,078 eligible persons, 5,201 (57%) agreed to participate. The
study was approved by the institutional review board at each
participating center, and clinically important findings were
communicated to both the participants and their physicians.
Study design and objectives have been published previously
(1). In brief, the baseline examination, conducted in 1989 to
1990, consisted of an extensive medical history, physical exam-
ination, 12-lead electrocardiogram, spirometry, and echocardi-
ography. Laboratory evaluation included serum chemistry de-
terminations, an oral glucose tolerance test and assessment of
levels of fasting plasma lipids (derived beta-quantification),
Lp(a) and hemostatic factors (fibrinogen, factors VII and
VIII).
Echocardiography protocol. Echocardiographic studies
were technically adequate in 5,176 (.99%) of subjects and
were recorded on super-VHS tape with use of a Toshiba
SSH-160A cardiac ultrasound machine as previously described
(15). Two-dimensional (2D) assessment of the aortic valve was
performed from the parasternal long- and short-axis and apical
long-axis views. Videotapes were sent to the Echocardiography
Reading Center (located at the University of California,
Irvine), where abnormalities of the aortic valve were coded as
aortic stenosis, bicuspid aortic valve, aortic sclerosis, aortic
valve vegetation or prosthetic aortic valve. Sclerosis was de-
fined as increased echogenicity and leaflet thickness without
restriction of leaflet motion. Aortic stenosis was defined as
thickened leaflets with reduced systolic opening on 2D imaging
and an increased anterograde velocity ($2.5 m/s by continuous
wave Doppler ultrasound) across the valve.
For this substudy, aortic valve morphology was reanalyzed
in detail by two of us (B.F.S., C.M.O.) without knowledge of
the Reading Center coding. A total of 201 studies were
selected by the Coordinating Center to include all 92 coded as
aortic stenosis and 109 not coded as aortic stenosis (randomly
selected). On review of the original videotapes, each valve
leaflet was graded on a scale of 0 (normal) to 31 (severe) for
leaflet thickening and calcification. A total valve score was
calculated as the sum of the individual leaflet scores divided by
the number of leaflets. This score was used to classify the aortic
valve as normal or abnormal (score $0.25).
Agreement between the Reading Center coding and the
reanalysis of aortic valve morphology in 201 subjects was
assessed after exclusion of poor quality studies (n 5 4) and
cases with an aortic valve replacement (n 5 8). Leaflet
thickening or calcification was confirmed in 27 (73%) of 37
aortic valves originally classified as sclerotic and in 70 (80%) of
87 classified as stenotic. Of valves originally classified as
neither sclerotic or stenotic, 65 (84%) of 77 did not demon-
strate significant leaflet thickening or calcification. Of the 12
discrepant cases, only 1 had more than mild leaflet change
(score$1.0). There was no evidence of subvalvular obstruction
on any of 201 reviewed studies. Given the good agreement
between the initial Reading Center coding and the reanalysis
(kappa 5 0.62), the Reading Center coding was used for all
subsequent analyses in order to take advantage of the large
sample size.
Statistical analyses. Bivariate analysis was performed by
using unpaired t tests and chi-square analysis with the signifi-
cance level set at 0.01. Independent risk factors for aortic valve
sclerosis or stenosis were determined by stepwise logistic
regression analysis. Statistical analysis was performed by using
SPSS/PC plus V4.0 (SPSS Inc., 1990) and EGRET (Statistics
and Epidemiology Research Corp., 1990) with default settings.
A p value of 0.01 was used for entry into the logistic regression
analysis.
Results
Prevalence of aortic sclerosis and stenosis. Table 1 shows
the prevalence of sclerosis and stenosis on 2D echocardiogra-
phy for the total study group and by gender and age groups.
The variables chosen for analysis were based on our hypothesis
that aortic valve disease has risk factors similar to those of
atherosclerosis. To exclude subjects with rheumatic or congen-
ital aortic valve disease, we excluded from the analysis subjects
coded as having aortic valve replacement (n 5 23), mitral
Abbreviations and Acronyms
CHS 5 Cardiovascular Health Study
HDL 5 high density lipoprotein
HDLc 5 high density lipoprotein cholesterol
LDL 5 low density lipoprotein
LDLc 5 low density lipoprotein cholesterol
Lp(a) 5 lipoprotein(a)
2D 5 two-dimensional
Table 1. Prevalence of Aortic Valve Abnormalities
by Echocardiography
Aortic Valve Abnormality
None Sclerosis Stenosis
Valve
Replacement
All subjects 3,736 (72%) 1,329 (26%) 88 (2%) 23 (0.4%)
Women 2,249 (76%) 641 (22%) 43 (1.5%) 12 (0.4%)
Men 1,487 (67%) 688 (31%) 45 (2%) 11 (0.5%)
65–74 years old 2,684 (78%) 697 (20%) 43 (1.3%) 16 (0.5%)
Women 1,654 (82%) 344 (17%) 20 (1.0%) 9 (0.4%)
Men 1,030 (73%) 353 (25%) 23 (1.6%) 7 (0.5%)
75–84 years old 962 (62%) 542 (35%) 37 (2.4%) 7 (0.5%)
Women 546 (66%) 259 (31%) 22 (2.7%) 3 (0.4%)
Men 416 (58%) 283 (39%) 15 (2.1%) 4 (0.6%)
851 years old 90 (48%) 90 (48%) 8 (4%) 0 (0%)
Women 49 (56%) 38 (43%) 1 (1%) 0
Men 41 (41%) 52 (52%) 7 (7%) 0
Data are expressed as number (%) of subjects.
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stenosis or mitral valve replacement, or both (n5 37), bicuspid
aortic valve (n 5 4) or aortic valve endocarditis (n 5 2) and
those with inadequate echocardiographic data (n 5 25). Fac-
tors associated with the presence of degenerative aortic valve
disease, defined as stenosis or sclerosis, based on bivariate
analysis are shown in Table 2. Note the associations of aortic
sclerosis or stenosis with age, hip circumference, coagulation
factors (factor VII), serum high density lipoprotein (HDL) and
Lp(a) levels, fasting glucose and 2-h insulin levels, serum
creatinine and systolic blood pressure.
Multiple logistic regression analysis. Continuous variables
that competed for entry into the multiple logistic regression
model included age, height, weight, waist and hip circumfer-
ence, average systolic and diastolic blood pressure, heart rate,
factors VII and VIII, fibrinogen, triglycerides, HDL choles-
terol (HDLc), LDL cholesterol (LDLc), Lp(a), glucose, insu-
lin, albumin, potassium, uric acid and creatinine. Categoric
variables that competed for entry included gender, smoking
(past, present, never), congestive heart failure (none, possible,
definite), coronary heart disease and self-reported histories of
hypertension, diabetes and estrogen use.
The results of the stepwise multiple logistic regression are
shown in Table 3. The odds ratio and associated 95% confi-
dence intervals were estimated to assess the magnitude of the
association between these factors and the presence of aortic
sclerosis or stenosis. The odds ratio was 2.18 for each 10-year
increase in age. Male gender was associated with a twofold
excess risk. Relative to never smoking, present smoking was
associated with a 35% increase in risk. Lp(a) was strongly
associated with an increased risk of aortic valve disease. A
history of hypertension conveyed a 20% excess risk. The odds
ratio associated with increases in LDLc from the 25th to 75th
percentile level was significant but small. Exclusion of partici-
pants with aortic stenosis from the multivariate analysis did not
significantly alter the findings.
Discussion
Echocardiographic data from the Cardiovascular Health
Study have confirmed that aortic valve disease is common in
the elderly. Approximately one in four subjects had visually
apparent leaflet thickening or calcification, or both, and the
prevalence increased with advancing age. These results are in
agreement with the older Helsinki Aging Study (2) in which
aortic valve calcification was found in .50% of subjects aged
75 to 86 years. Aortic valve sclerosis and stenosis were both
considered to represent calcific valve disease because substan-
Table 2. Bivariate Relations of Clinical Variables to Aortic
Valve Abnormalities
Normal
(n 5 3,709)
Sclerosis/
Stenosis
(n 5 1,405)
p
Value
A. Continuous Variables
Age (yr) 72.0 6 5.2 74.7 6 6.1 ,0.0001
Height (cm) 164.8 6 9.5 165.2 6 9.7 NS
Weight (kg) 73 6 14.6 71.7 6 13.8 NS
Waist circumference (cm) 93.76 13.1 94.0 6 12.3 NS
Hip circumference (cm) 101.96 10.0 100.7 6 8.8 0.0002
Fibrinogen (mg/dl) 319.2 6 63.7 324.0 6 70.3 NS
Factor VII (%) 126.46 33.0 123.4 6 36.6 0.009
Factor VIII (%) 121.66 37.1 122.9 6 38.4 NS
Cholesterol (mg/dl) 214.9 6 39.0 214.3 6 39.7 NS
Triglycerides (mg/dl) 141.3 6 74.3 145.9 6 89.0 NS
HDL (mg/dl) 54.5 6 15.8 52.3 6 15.4 ,0.0001
LDL (mg/dl) 132.8 6 35.6 133.9 6 35.9 NS
Lp(a) (mg/dl) 50.7 6 48.5 62.3 6 71.4 ,0.001
Fasting glucose (mg/dl) 109.26 31.7 112.5 6 40.7 0.007
Fasting insulin (mU/ml) 16.4 6 19.7 17.8 6 32.9 NS
2-h insulin (mU/ml) 86.1 6 65.0 79.6 6 58.4 0.002
2-h glucose (mg/dl) 146.26 56.4 150.7 6 62.5 NS
Albumin (g/dl) 4.0 6 0.3 4.0 6 0.3 NS
Potassium (mEq/liter) 4.2 6 0.4 4.2 6 0.4 NS
Uric acid (mg/dl) 5.66 1.5 5.8 6 1.6 0.0003
Creatinine (mg/dl) 1.0 6 0.3 1.1 6 0.4 ,0.0001
Systolic BP (mm Hg) 134.96 21.2 138.0 6 22.1 ,0.0001
Diastolic BP (mm Hg) 70.36 11.3 69.7 6 12.0 NS
B. Categoric Variables
Smoking
Never 1,707 (47%) 608 (44%) NS
Past 1,526 (42%) 607 (44%)
Present 422 (12%) 162 (12%)
Hypertension*
No 2,068 (57%) 710 (52%) 0.001
Yes 1,584 (43%) 668 (48%)
Diabetes*
No 3,301 (90%) 1,241 (89%) NS
Yes 382 (10%) 148 (11%)
Estrogen use†
No 1,928 (86%) 607 (90%) NS (0.016)
Yes 300 (14%) 67 (10%)
Coronary heart disease‡
No 2,838 (77%) 987 (70%) ,0.0001
Yes 871 (23%) 418 (30%)
*Self-reported. †Among women (n 5 2,943) only. ‡Coronary heart disease
was defined by physician diagnosis of myocardial infarction, angina, angioplasty,
coronary artery bypass grafting or by silent myocardial infarction on electrocar-
diography. Data are expressed as mean value 6 SD or number (%) of subjects.
BP 5 blood pressure; HDL 5 high density lipoprotein; LDL 5 low density
lipoprotein; Lp(a) 5 lipoprotein(a).
Table 3. Clinical Factors Associated With Aortic Stenosis or
Sclerosis by Stepwise Multiple Logistic Regression
Variable
p
Value
Odds
Ratio
95%
Confidence
Limits
Age ,0.001 2.18* 2.15, 2.20
Male gender ,0.001 2.03 1.7, 2.5
Lp(a) ,0.001 1.23† 1.14, 1.32
Height (cm) 0.001 0.84‡ 0.75, 0.93
History of hypertension 0.002 1.23 1.1, 1.4
Present smoking 0.006 1.35 1.1, 1.7
LDLc (mg/dl) 0.008 1.12† 1.03, 1.23
*6 75th vs. 25th percentile. †6 10-year increase. ‡6 10-unit increase.
LDLc 5 low density lipoprotein cholesterol; Lp(a) 5 lipoprotein(a).
632 STEWART ET AL. JACC Vol. 29, No. 3
AORTIC STENOSIS RISK FACTORS March 1, 1997:630–4
tial clinical and histopathologic data (2–10) suggest that these
conditions represent different stages of the same disease
process.
Predictors of aortic valve disease. It is unlikely that degen-
erative aortic valve disease is merely related to age-associated
“wear and tear.” The multivariate analysis is most helpful in
evaluating associations with aortic valve disease, as bivariate
analysis fails to incorporate interactions among the clinical
variables (thus accounting for the apparent differences be-
tween the bivariate and multivariate analyses). Stepwise logis-
tic regression analysis identified eight independent predictors
of aortic valve disease. Age was not an unexpected predictor,
having been noted in previous studies. In addition to age, we
hypothesized that atherosclerosis risk factors would also be
risk factors for degenerative aortic valve disease. This hypoth-
esis was based on several lines of evidence including 1) the
similarities between early lesions of aortic valve disease and
atherosclerosis, including lipid deposition (6); 2) the associa-
tion between aortic valve lesions and hyperlipidemia (16,17) or
elevated LP(a) levels (9); and 3) the location of the focal
changes of sclerosis on the aortic side of the leaflets (18),
suggesting endothelial injury from low shear stress and high
tensile stress as possible initiating factors in the disease process
(19,20). Endothelial injury and disruption could then lead to
inflammatory cell infiltration and lipid deposition analogous to
the early atherosclerotic process (4,21).
Previous studies of degenerative aortic valve disease have
found associations with atherosclerosis risk factors, but the
significant factors have varied among studies. Aronow et al.
(11) studied a very elderly population with 2D echocardiogra-
phy and found an association between aortic valve disease and
hypertension, diabetes, hypercholesterolemia and low HDLc.
In the Helsinki Aging Study (14), hypertension, age and a low
body mass index were independent predictors of aortic valve
calcification; cholesterol, smoking and diabetes were not. The
Jichi Medical School study (9) identified an association be-
tween Lp(a) levels and aortic valve sclerosis. The current study,
the largest study to date examining this question, shows that
age, gender, height, hypertension, smoking, Lp(a) and LDLc
are independent predictors of degenerative aortic valve dis-
ease. The magnitude of the risk conveyed by these factors is
particularly high for age, male gender, hypertension, smoking
and Lp(a), with only a small increase in risk evident for
elevations of LDLc (Table 2). In general, the magnitude of the
association is similar to that for coronary artery disease risk
factors in the elderly (22).
Mechanism of association. Potential explanations for the
association of these clinical factors with aortic valve disease
include the possibility that hypertension results in abnormally
high tensile stress on the aortic leaflets. Alternatively, turbu-
lent flow patterns associated with high volume flow rates may
lead to low shear stress, resulting in endothelial injury and
disruption as is seen in atherosclerotic lesions (18,23). Ele-
vated levels of LDLc and Lp(a) may facilitate lipid deposition
after endothelial injury from any cause. Smoking may increase
the risk for aortic valve disease through mechanisms analogous
to those postulated for atherosclerosis, including adverse ef-
fects on endothelial permeability and lipoprotein oxidation
(23).
The explanation for an inverse association between height
and aortic valve disease is not as readily apparent. Lindroos et
al. (14) found an inverse relation between aortic valve calcifi-
cation and body mass index, and they postulated that the
relation might be mediated through osteoporosis. Loss of
height in osteoporosis is well described (24), again raising the
possibility of an association between degenerative aortic valve
disease and osteoporosis. Other possibilities include hemody-
namic and shear stress effects related to the length of the
peripheral vasculature.
Study limitations. The major limitations of this study are
that it is a cross-sectional analysis and includes only subjects
$65 years of age, which may bias the results against an even
stronger relation between these risk factors and aortic valve
disease. In addition, the time available for echocardiographic
evaluation of the aortic valve was limited and quantitative
Doppler data were not available. On the other hand, echocar-
diography readers did not know the clinical and risk factor
status, and the subjects were not highly selected. Agreement
between the Reading Center coding of aortic valve morphol-
ogy and a detailed rereview of a subset of the studies was not
perfect, but the differences are unlikely to have affected the
results given the large sample size and, in any case, would bias
the results against observing significant associations.
Summary. In summary, several clinical factors associated
with degenerative aortic valve disease have been identified,
including age, gender, Lp(a), LDLc, hypertension and smok-
ing. Although these clinical factors also have been associated
with atherosclerosis, other factors must be important for the
development of significant aortic valve disease because only
50% of patients with severe aortic stenosis also have significant
coronary artery disease (25–27). Further understanding of
both the cellular and molecular mechanisms involved in the
pathogenesis of degenerative aortic valve disease and the risk
factors for this disease may lead to interventions that prevent
or delay disease progression. In addition, studies to determine
whether control of risk factors prevents aortic valve disease
appear to be warranted.
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